Stabellini N, Kaur J, Owusu C, Moftakhar B, et al. Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res Treat 2026;215:59.
PMID: 41557039